Related references
Note: Only part of the references are listed.Drug resistance profiles and influencing factors among HIV-infected children and adolescents receiving long-term ART: a multicentre observational study in China
Liting Yan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)
Nirmatrelvir Plus Ritonavir: First Approval
Yvette N. Lamb
DRUGS (2022)
Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2
Yao Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
What coronavirus 3C-like protease tells us: From structure, substrate selectivity, to inhibitor design
Muya Xiong et al.
MEDICINAL RESEARCH REVIEWS (2021)
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
Dafydd R. Owen et al.
SCIENCE (2021)
The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract
Yuejun Shi et al.
EMERGING MICROBES & INFECTIONS (2021)
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses
Yanmei Hu et al.
ACS INFECTIOUS DISEASES (2021)
Establishment of Full-Length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats
Gang Wang et al.
JOURNAL OF VIROLOGY (2021)
Feline Coronavirus Antivirals: A Review
Manon Delaplace et al.
PATHOGENS (2021)
Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis
Khan Sharun et al.
ANNALS OF MEDICINE AND SURGERY (2021)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural Basis for Inhibiting Porcine Epidemic Diarrhea Virus Replication with the 3C-Like Protease Inhibitor GC376
Gang Ye et al.
VIRUSES-BASEL (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Neurological manifestations of COVID-19 and other coronaviruses: a systematic review
Alyne Oliveira Correia et al.
NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH (2020)
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma et al.
CELL RESEARCH (2020)
Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats
Aaron M. Izes et al.
VETERINARY QUARTERLY (2020)
The N-Terminal Domain of Spike Protein Is Not the Enteric Tropism Determinant for Transmissible Gastroenteritis Virus in Piglets
Gang Wang et al.
VIRUSES-BASEL (2019)
Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges
Chandrashekhar Voshavar
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor
Krishani Dinah Perera et al.
VETERINARY MICROBIOLOGY (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis
Niels C. Pedersen et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2018)
Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses
Bryan A. Johnson et al.
VIROLOGY (2018)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin
Peng Zhou et al.
NATURE (2018)
Potential Therapeutic Agents for Feline Calicivirus Infection
Tulio M. Fumian et al.
VIRUSES-BASEL (2018)
Hepatitis C virus NS3/4a protease inhibitors
John A. McCauley et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Glial response in the central nervous system of cats with feline infectious peritonitis
Leonardo P. Mesquita et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2016)
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Shuo Su et al.
TRENDS IN MICROBIOLOGY (2016)
Polymorphisms and resistance mutations of hepatitis C virus on sequences in the European hepatitis C virus database
Dimas Alexandre Kliemann et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Recent progress in the discovery of inhibitors targeting coronavirus proteases
Haofeng Wang et al.
VIROLOGICA SINICA (2016)
X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: Structural implications for drug design
Sarah E. St. John et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Middle East respiratory syndrome
Alimuddin Zumla et al.
LANCET (2015)
Prediction and biochemical analysis of putative cleavage sites of the 3C-like protease of Middle East respiratory syndrome coronavirus
Andong Wu et al.
VIRUS RESEARCH (2015)
HIV-1 transmitted drug resistance-associated mutations and mutation co-variation in HIV-1 treatment-naive MSM from 2011 to 2013 in Beijing, China
Yang Jiao et al.
BMC INFECTIOUS DISEASES (2014)
Altered Viral Fitness and Drug Susceptibility in HIV-1 Carrying Mutations That Confer Resistance to Nonnucleoside Reverse Transcriptase and Integrase Strand Transfer Inhibitors
Zixin Hu et al.
JOURNAL OF VIROLOGY (2014)
Structural and inhibitor studies of norovirus 3C-like proteases
Daisuke Takahashi et al.
VIRUS RESEARCH (2013)
Hepatitis C virus protease inhibitor-resistance mutations: Our experience and review
Shuang Wu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Middle East Respiratory Syndrome-coronavirus infection: An overview
Jsggar A. Al-Tawfiq
JOURNAL OF INFECTION AND PUBLIC HEALTH (2013)
Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses
Yunjeong Kim et al.
JOURNAL OF VIROLOGY (2012)
Hepatitis C virus resistance to protease inhibitors
Philippe Halfon et al.
JOURNAL OF HEPATOLOGY (2011)
Profiling of Substrate Specificities of 3C-Like Proteases from Group 1, 2a, 2b, and 3 Coronaviruses
Chi-Pang Chuck et al.
PLOS ONE (2011)
The effect of transmitted HIV-1 drug resistance on pre-therapy viral load
Linda Harrison et al.
AIDS (2010)
Functional and Genetic Studies of the Substrate Specificity of Coronavirus Infectious Bronchitis Virus 3C-Like Proteinase
Shouguo Fang et al.
JOURNAL OF VIROLOGY (2010)
Profiling of Substrate Specificity of SARS-CoV 3CLpro
Chi-Pang Chuck et al.
PLOS ONE (2010)
Emergence of Multiclass Drug-Resistance in HIV-2 in Antiretroviral-Treated Individuals in Senegal: Implications for HIV-2 Treatment in Resouce-Limited West Africa
Geoffrey S. Gottlieb et al.
CLINICAL INFECTIOUS DISEASES (2009)
Genetics and Pathogenesis of Feline Infectious Peritonitis Virus
Meredith A. Brown et al.
EMERGING INFECTIOUS DISEASES (2009)
Clinical significance of human immunodeficiency virus type 1 replication fitness
Carrie Dykes et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Production of authentic SARS-CoV Mpro with enhanced activity:: Application as a novel tag-cleavage endopeptidase for protein overproduction
Xiaoyu Xue et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Relative replication fitness of efavirenz-resistant mutants of HIV-1: Correlation with frequency during clinical therapy and evidence of compensation for the reduced fitness of K103N+L100I by the nucleoside resistance mutation L74V
Christine E. Koval et al.
VIROLOGY (2006)
The substrate specificity of SARS coronavirus 3C-like proteinase
KQ Fan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Medical progress: HIV drug resistance
F Clavel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase
KQ Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Mutational analysis of the active centre of coronavirus 3C-like proteases
A Hegyi et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants
C Dykes et al.
VIROLOGY (2001)
Share Paper
